As an example, mutations in the BRCA1 and BRCA2 genes account for around 2%–3% of all breast cancer cases [1,2], although more prevalent founder mutations in these genes can explain up to about 10% of the disease in some populations [3,4,5,6,7]. The gene discussed is BRCA2; the disease is breast carcinoma.